PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Clinical trials for PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA trials appear
Sign up with your email to follow new studies for PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain cancer trial tests less chemo for same results
Disease control OngoingThis study is comparing two chemotherapy approaches for adults with newly diagnosed primary brain lymphoma. Researchers want to see if a shorter, less intensive chemotherapy regimen followed by stem cell transplant works as well as the standard longer treatment. The goal is to co…
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Phase: PHASE3 • Sponsor: Klinikum Stuttgart • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for aggressive brain cancer as scientists test Dual-Attack therapy
Disease control OngoingThis early-stage study is testing the safety and initial effectiveness of combining two drugs, acalabrutinib and durvalumab, for adults with primary central nervous system (CNS) lymphoma, a rare and aggressive cancer of the brain or spine. The trial is for patients whose cancer h…
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Experimental Four-Target antibody tested for tough brain cancers
Disease control OngoingThis early-stage study is testing a new, four-target antibody drug called GNC-038 in adults with primary or secondary brain lymphoma that has come back or hasn't responded to other treatments. The main goals are to find a safe dose, understand how the body processes the drug, and…
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC